Nonami, A., Matsuda, K., Funakoshi, K., Kato, R., Takahashi, H., & Edahiro, Y. (Oct 1, 2025). Impact of Dose‐Escalation Design on the Safety and Development of Anticancer Drugs in Clinical Trials. Clinical and Translational Science. https://doi.org/10.1111/cts.70367
Copiat
No s'ha pogut copiar
Cita Chicago (17th ed.)
Nonami, Atsushi, Kensuke Matsuda, Kouta Funakoshi, Ryosuke Kato, Hideaki Takahashi, i Yoko Edahiro. "Impact of Dose‐Escalation Design on the Safety and Development of Anticancer Drugs in Clinical Trials."
Clinical and Translational Science Oct 1, 2025. https://doi.org/10.1111/cts.70367.
Copiat
No s'ha pogut copiar
Cita MLA (9th ed.)
Nonami, Atsushi, et al. "Impact of Dose‐Escalation Design on the Safety and Development of Anticancer Drugs in Clinical Trials."
Clinical and Translational Science, Oct 1, 2025, https://doi.org/10.1111/cts.70367.
Copiat
No s'ha pogut copiar
Atenció: Aquestes cites poden no estar 100% correctes.